Concepedia

István Gyertyán

IG

55

Publications

2.7K

Citations

28

H-Index

1991

Active since

Affiliations

Gedeon Richter (Hungary)(Current)

Semmelweis University

Egis Pharmaceuticals (Hungary)

Allergan (United States)

Institute of Cognitive Neuroscience and Psychology

István Gyertyán is an author at Gedeon Richter (Hungary) specializing in medicine, neuropharmacology, and social sciences.

ORCID

Top concepts

Publications per year

1991–2022

55

Publications

55

Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist–Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile

Béla Kiss, Attila Horváth, Zsolt Némethy et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 358 citations

Long-term effects of cariprazine exposure on dopamine receptor subtypes

Yong Kee Choi, Nika Adham, Béla Kiss et al. · CNS Spectrums · 2013 · 177 citations

Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents

István Gyertyán, Béla Kiss, Katalin Sághy et al. · Neurochemistry International · 2011 · 144 citations

, , +8

mCPP-induced anxiety in the light-dark box in rats - a new method for screening anxiolytic activity

András Bilkei‐Gorzó, István Gyertyán, György Lévay · Psychopharmacology · 1998 · 131 citations

, , +13

Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats

Judit Laszy, I. Laszlovszky, István Gyertyán · Psychopharmacology · 2004 · 127 citations

, , +11

Rows per page

1–5 of 55